Plasmodium falciparum: development of a transgenic line for screening antimalarials using firefly luciferase as the reporter

Exp Parasitol. 2008 Sep;120(1):80-7. doi: 10.1016/j.exppara.2008.05.003. Epub 2008 May 29.

Abstract

High-throughput screening (HTS) of small-molecule libraries against pharmacological targets is a key strategy of contemporary drug discovery. This study reports a simple, robust, and cell-based luminescent method for assaying antimalarial drugs. Using transfection technology, we generated a stable Plasmodium falciparum line with high levels of firefly luciferase expression. A luciferase assay based on this parasite line was optimized in a 96-well plate format and used to compare with the standard [(3)H] hypoxanthine radioisotope method. The 50% inhibitory concentrations (IC(50)s) of chloroquine, artesunate, artemether, dihydroartemisinin and curcumin obtained by these two methods were not significantly different (P>0.05, ANOVA). In addition, this assay could be performed conveniently with a luminescence plate reader using unsynchronized stages within as early as 12h. Furthermore, the luciferase assay is robust with a Z' score of 0.77-0.92, which suggests the feasibility for further miniaturization and automation.

Publication types

  • Research Support, N.I.H., Extramural
  • Validation Study

MeSH terms

  • Animals
  • Animals, Genetically Modified / genetics*
  • Animals, Genetically Modified / metabolism
  • Antimalarials / pharmacology*
  • Cloning, Molecular
  • Erythrocytes / parasitology
  • Genes, Reporter
  • Humans
  • Inhibitory Concentration 50
  • Linear Models
  • Luciferases, Firefly / biosynthesis
  • Luciferases, Firefly / genetics*
  • Luminescent Agents
  • Plasmodium falciparum / drug effects*
  • Plasmodium falciparum / enzymology
  • Plasmodium falciparum / genetics*
  • Reproducibility of Results
  • Transfection

Substances

  • Antimalarials
  • Luminescent Agents
  • Luciferases, Firefly